Recombinant PSMA (Rosopatamab Biosimilar) antibody

Catalog No. ABIN7538085

The Humanized Chimeric anti-PSMA (Rosopatamab Biosimilar) antibody has been validated for ELISA and WB. It is suitable to detect PSMA (Rosopatamab Biosimilar) in samples from Human.

Quick Overview for Recombinant PSMA (Rosopatamab Biosimilar) antibody (ABIN7538085)

Target: PSMA (Rosopatamab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Chimeric

Conjugate: This PSMA (Rosopatamab Biosimilar) antibody is un-conjugated

Application: ELISA, Western Blotting (WB)

Grade: Research Grade

Product Details anti-PSMA (Rosopatamab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Rosopatamab Biosimilar - Anti-FOLH1 mAb - Research Grade

Characteristics: Antibody Type: IgG1-kappa

Purification: Recombinant antibody expressed in mammalien cells and purified.

Purity: > 85%

Isotype: IgG1 kappa

Application Details

Restrictions: For Research Use only

Handling

Buffer: PBS buffer PH7.5

Storage: -80 °C

Storage Comment: store at -80°C

Target Details for PSMA (Rosopatamab Biosimilar)

Target: PSMA (Rosopatamab Biosimilar)

Background: Rosopatamab (HuJ591) is a humanized anti-PSMA IgG1 monoclonal antibody that can be used in cancer research, especially prostate cancer. Rosopatamab can be linked to the low-energy beta-emitting radioisotope lutetium-177 (177Lu) through the bifunctional chelator DOTA-NHS ester to obtain a radioimmunoconjugate that targets malignant prostate cells with high efficiency.

CAS-No: 2260767-49-3